Clinical Trials Offer Options for Mesothelioma

Mesothelioma is a devastating malignancy in the lining of the lungs and other internal organs. It affects about 2,500 Americans annually, most of them industrial workers who came in contact with the toxic mineral asbestos 20 to 50 years ago. Because the prognosis is generally poor for mesothelioma there are a number of clinical trials underway to find more effective treatments.

Clinical trials are organized formal studies of a new drug or other treatment protocol in human patients. They can be an important source of hope and help for patients, especially those who may have few proven treatment options. But, in order for clinical trials to be effective, a certain number of mesothelioma patients must be willing to take the chance that the study will either improve their own condition or provide doctors with valuable information that could eventually help future patients.

Different mesothelioma clinical trials are searching for study subjects who meet various criteria. For instance, some clinical trials are recruiting mesothelioma patients who have never been treated, while others are looking for patients who gained no therapeutic benefit from previous treatments. Still others may be looking for patients in a certain age range or whose mesothelioma is in a particular stage.

The NIH currently lists 41 active clinical trials for mesothelioma in the U.S. Among them are:

– A Phase I/II trial of the peptide CBP501 and its potential for enhancing pemetrexed/cisplatin chemotherapy treatment – A pilot study of allogeneic tumor cell vaccine in combination with an oral medication – A Phase II trial of pleurectomy/decortication with intraoperative heated chemotherapy – A Phase II study of the oral medication Milataxel (known as a taxane) – A Phase II study on the effectiveness of following chemotherapy and pleurectomy/decortication surgery with Intensity Modulated Radiation Therapy (IMRT) – A Phase II study of a lung-sparing trimodal approach to mesothelioma – A study on anti-TGF monoclonal antibody treatment (gene therapy) for relapsed malignant pleural mesothelioma – A study on intrapleural gene transfer for pleural mesothelioma

Often, a patient’s physician can assist in finding active clinical trials in their area for which the patient might be eligible. The National Cancer Institute, a division of the National Institutes of Health and a sponsor of many clinical trials, also offers an online step-by-step guide for mesothelioma patients interested in finding and participating in a clinical trial. In addition, Abby Palmer MSW, a clinical consultant with Cancer Monthly has information on the results of many of these newer treatments. Abby may be reached at: 619-261-7922.

Sources:

National Cancer Institute/NIH Clinical Trials, List of active clinical trials in the U.S

"It has been over four years now and I can honestly say I am doing great. I highly recommend this book because it is inspirational and educational."

— Tom Crittenden, Maricopa, Az.

*Note: We have limited copies available for free. Free copies of the book are only available in the United States, Australia and New Zealand.

Recent Article

Mindfulness May Help Mesothelioma Patients Cope

December 13, 2017

There is new evidence that lung cancer patients who receive training in mindfulness can dramatically lower their feelings of stress and anxiety. Lung-related cancers like pleural mesothelioma and non-small cell lung cancer have been shown to produce some of the highest levels of anxiety of any cancer. Although there are differences between the asbestos cancer malignant mesothelioma and other types of lung cancer, both malignancies tend … Continue reading Mindfulness May Help Mesothelioma Patients Cope»

Disclaimer

Surviving Mesothelioma® is registered with the United States Patent and Trademark Office by Cancer Monthly, Inc. and the website is owned and managed by Cancer Monthly, Inc. All of the information provided on this website or by an employee or contractor of Cancer Monthly is for informational purposes only. This website is not a substitute for professional medical advice, examination, diagnosis or treatment. This website should not be used for diagnosing or treating a health problem or disease and it is not a substitute for professional care. You should always seek the advice of your physician or other qualified health professional before starting any new treatment or making any changes to an existing treatment. You should not delay in seeking or disregard medical advice based on information on this website or by any employee or contractor of Cancer Monthly.